DE924085C - Process for the preparation of nitric acid esters of oxyalkylxanthines - Google Patents

Process for the preparation of nitric acid esters of oxyalkylxanthines

Info

Publication number
DE924085C
DE924085C DES34639A DES0034639A DE924085C DE 924085 C DE924085 C DE 924085C DE S34639 A DES34639 A DE S34639A DE S0034639 A DES0034639 A DE S0034639A DE 924085 C DE924085 C DE 924085C
Authority
DE
Germany
Prior art keywords
nitric acid
acid esters
oxyalkylxanthines
preparation
theophylline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DES34639A
Other languages
German (de)
Inventor
Hans Dr Anselm
Karl Dr Zipf
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SAGITTA WERK GmbH
Original Assignee
SAGITTA WERK GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SAGITTA WERK GmbH filed Critical SAGITTA WERK GmbH
Priority to DES34639A priority Critical patent/DE924085C/en
Application granted granted Critical
Publication of DE924085C publication Critical patent/DE924085C/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/10Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 3 and 7, e.g. theobromine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • C07D473/02Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • C07D473/08Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3 with methyl radicals in positions 1 and 3, e.g. theophylline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

Verfahren zur Herstellung von Salpetersäureestern von Oxalkylxanthinen In der Therapie werden an Stelle von Xanthinbasen, z. B. von Theophyllin und Theobromin oder deren salzartigen Verbindungen, mit Vorliebe die entsprechenden Oxalkylderivate verwendet. Sie zeichnen sich bei gleichem Wirkungscharakter durch bessere Verträglichkeit aus.Process for the preparation of nitric acid esters of oxalkylxanthines In therapy, instead of xanthine bases, e.g. B. of theophylline and theobromine or their salt-like compounds, preferably the corresponding oxyalkyl derivatives used. They are characterized by better tolerability with the same effect the end.

Es wurde gefunden, daß sich derartige Oxalkylxanthine, die im Oxalkylrest mindestens 2 Kohlenstoffatome enthalten, durch Behandlung mit Nitrierungsmitteln, z. B. wasserfreier Salpetersäure, auf einfache Weise und mit guter Ausbeute in Salpetersäureester überführen lassen. Bei Anwendung eines entsprechenden Überschusses an Salpetersäure werden bei vorzugsweise niedriger Temperatur und bei relativ kurzer Einwirkungszeit sämtliche OH-Gruppen verestert, ohne daß eine nennenswerte oxydative Aufspaltung des Xanthinmoleküls erfolgt. An Stelle von wasserfreier Salpetersäure läßt sich auch das bekannte Gemisch von hochprozentiger Salpetersäure und konzentrierter Schwefelsäure verwenden.It has been found that such oxalkylxanthines in the oxalkyl radical contain at least 2 carbon atoms by treatment with nitrating agents, z. B. anhydrous nitric acid, in a simple manner and with good yield in nitric acid ester get convicted. When using an appropriate excess of nitric acid are preferably at a low temperature and with a relatively short exposure time all OH groups are esterified without any significant oxidative splitting of the xanthine molecule takes place. Instead of anhydrous nitric acid can also the well-known mixture of high percentage nitric acid and concentrated sulfuric acid use.

Die neuen Verbindungen besitzen gleichzeitig die pharmakologische Wirkung der Xanthinbasen und der Nitrokörper, wie Nitroglycerin. Sie zeichnen sich insbesondere bei einem höheren Gehalt an Nitrogruppen durch ihre therapeutische, namentlich blutdrucksenkende Wirkung aus.The new compounds also have the pharmacological one Effect of the xanthine bases and the nitro bodies, such as nitroglycerin. You stand out especially with a higher content of nitro groups due to their therapeutic, especially antihypertensive effects.

Es wurde bereits ein Verfahren zur Herstellung der Salpetersäureester der I, 3-Dialkyl-7-oxymethylxanthine beschrieben (vgl. die USA.-Patentschrift 2 351 843). Danach werden I, 3-Dialkyl-xanthine durch Formaldehyd in die 7-Oxymethylverbindungen und anschließend mittels Thionylchlorid in die 7-Chlormethyl-xanthine übergeführt. Durch Umsetzung dieser Chlorverbindungen mit Silbernitrat entstehen die Salpetersäureester der 1, 3-Dialkyl-oxymethylxanthine. Eine direkte Veresterung der i, 3-Dialkyl-7-oxym.ethyl-xanthine mit Salpetersäure ist nach diesen Literaturangaben nicht durchführbar. Auf analoge Weise wurde auch der Salpetersäureester des 71-Oxy-8-chlorcoffeins dargestellt (vgl. die USA.-Patentschrift 2 35z 844).There has already been a process for making the nitric acid esters the I, 3-dialkyl-7-oxymethylxanthine described (see. The USA. Patent 2 351 843). Then 1,3-dialkyl-xanthines are converted into 7-oxymethyl compounds by means of formaldehyde and then converted into the 7-chloromethyl-xanthine by means of thionyl chloride. The reaction of these chlorine compounds with silver nitrate results in them the Nitric acid esters of 1,3-dialkyl-oxymethylxanthines. A direct esterification the i, 3-dialkyl-7-oxym.ethyl-xanthine with nitric acid is according to this literature not feasible. The nitric acid ester of 71-oxy-8-chlorocaffeine was also made in an analogous manner (see U.S. Patent 2 35z 844).

Nach diesem sehr umständlichen und spezifischen Verfahren werden nur Mono-Salpetersäureester erhalten.Following this very cumbersome and specific procedure will only be Obtained mono-nitric acid ester.

Ein anderes Verfahren beschreibt die Nitrierufig von Theophyllin, wobei jedoch Nitroverbindungen, die keine Salpetersäureester sind, entstehen.Another method describes the nitration of theophylline, however, nitro compounds that are not nitric acid esters are formed.

Diesen bekannten und spezifischen Verfahren gegenüber ist das vorstehende Verfahren allgemein auf oxallkylierte Xanthine anwendbar. Es gestattet die Herstellung ein- und mehrwertiger Salpetersäureester oxalkylierter Xanthine auf einfache und wirtschaftliche Weise bei guter Ausbeute, sofern die Oxalkylgruppen mindestens 2 Kohlenstoffatome enthalten. Beispiel i 2o g wasserfreies 7-Oxäthyl-theophylhn, beispielsweise durch Einwirkung von Äthylenchlorhydrin auf Theophyllinnatrium hergestellt, werden bei -io° in ioo g wasserfreier Salpetersäure unter Rühren aufgelöst. Man hält die klare Lösung 3o Minuten auf o° und gießt dann in 21 Eiswasser. Nach einigen Stunden ist der Salpetersäureester völlig ausgefallen. Er ist schwer löslich in Wasser und Alkoholen, leichter in Aceton, Chlorkohlenwasserstoffen, Dioxan, Formamid, Eisessig. Durch Umkristallisieren, beispielsweise aus viel Wasser, erhält man aus obiger Menge 15 g des reinen Salpetersäureesters des 7-Oxäthyl-theophyllins in farblosen Nadeln. Die neue Verbindung schmilzt bei 187° unter Zersetzung.Opposite these known and specific methods is the above Process generally applicable to oxalkylated xanthines. It allows manufacture mono- and polyvalent nitric acid esters of oxalkylated xanthines on simple and economical way with good yield, provided that the oxalkyl groups are at least 2 Contain carbon atoms. Example i 2o g of anhydrous 7-Oxäthyl-theophylhn, for example produced by the action of ethylene chlorohydrin on theophylline sodium Dissolved at -io ° in 100 g of anhydrous nitric acid with stirring. You keep that clear solution to 0 ° for 30 minutes and then pour into 21 ice water. After a few hours the nitric acid ester has failed completely. It is sparingly soluble in water and Alcohols, lighter in acetone, chlorinated hydrocarbons, dioxane, formamide, glacial acetic acid. Recrystallization, for example from a lot of water, gives the above amount 15 g of the pure nitric acid ester of 7-oxethyl-theophylline in colorless needles. The new compound melts at 187 ° with decomposition.

Beispiel 2 409 wasserfreies 7-Dioxypropyl-theophyllin, aus Theophyllinnatrium und Glycerin-a-monochlorhydrin hergestellt, werden bei -io bis -5° in Zoo g wasserfreier Salpetersäure aufgelöst. Man läßt die klare, wenig gefärbte Lösung 2o bis 30 Minuten stehen, wobei man die Temperatur auf 5° ansteigen läßt. Man gießt unter Rühren in 2 bis 31 Eiswasser, läßt einen Tag stehen, trennt den Salpetersäureester ab, wäscht mit ammoniakhaltigem Wasser säurefrei und trocknet bei gelinder Wärme. Man erhält 39 g des Disalpetersäureesters des Dioxypropyl-theophyllins, der beim Umkristallisieren aus Butanol oder aus 3o°/piger Essigsäure in farblosen, bei 175 bis z76° unter Zersetzung schmelzenden Nadeln erhalten wird.Example 2 409 anhydrous 7-dioxypropyl-theophylline, produced from sodium theophylline and glycerol-a-monochlorohydrin, are dissolved at -io to -5 ° in zoo g of anhydrous nitric acid. The clear, slightly colored solution is left to stand for 20 to 30 minutes, the temperature being allowed to rise to 5 °. It is poured into 2 to 31 ice water with stirring, left to stand for a day, the nitric acid ester is separated off, washed acid-free with ammonia-containing water and dried under mild heat. 39 g of the disnitric acid ester of dioxypropyl-theophylline are obtained, which is obtained on recrystallization from butanol or from 30% acetic acid in colorless needles which melt at 175 to z76 ° with decomposition.

. Beispiel 3 Man löst io g trockenes.i-Dioxypropyl-theobromin, aus Theobrominnatrium und Glycerin-a-monochlorhydrin dargestellt, in 5o g wasserfreier Salpetersäure bei -io bis -5° unter Rühren auf. Zur Vervollständigung der Nitrierung läßt man die Temperatur des Nitrierungsgemisches im Laufe von 15 bis 2o Minuten auf io° ansteigen. Wenn sich die Mischung durch nitrose Gase braun färbt, ist die Temperatur zu erniedrigen. Man gießt in 21 kaltes Wasser oder etwa 3o°/oige Essigsäure, regt die Ausscheidung des Salpetersäureesters durch Reiben der Gefäßwand an und läßt zur Vervollständigung der Kristallisation mehrere Stunden stehen. Ausbeute 9 g. Durch Umkristallisieren aus 3o°/oiger Essigsäure erhält man den Disalpetersäureester des Dioxypropyltheobromins in farblosen Nadeln, die bei 153 bis 154° unter Zersetzung schmelzen.. EXAMPLE 3 10 g of dry i-dioxypropyl-theobromine, prepared from theobromine sodium and glycerol-a-monochlorohydrin, are dissolved in 50 g of anhydrous nitric acid at -io to -5 ° with stirring. To complete the nitration, the temperature of the nitration mixture is allowed to rise to 10 ° in the course of 15 to 20 minutes. If the mixture turns brown from nitrous gases, lower the temperature. It is poured into 21% cold water or about 30% acetic acid, the excretion of the nitric acid ester is stimulated by rubbing the wall of the vessel and left to stand for several hours to complete the crystallization. Yield 9 g. Recrystallization from 30% acetic acid gives the disnitric acid ester of dioxypropyl theobromine in colorless needles which melt at 153 to 154 ° with decomposition.

Claims (1)

PATENTANSPRUCH: Verfahren zur Herstellung von Salpetersäureestern von Oxalkylxanthinen, dadurch gekennzeichnet, daß man Oxalkylxanthine, die im Oxalkylrest mindestens 2 Kohlenstoffatome enthalten, vorzugsweise bei niedrigen Temperaturen mit üblichen Nitrierungsmitteln behandelt und die entstandenen Salpetersäureester durch Wasser oder wasserhaltige Flüssigkeiten ausfällt und isoliert. Angezogene Druckschriften Deutsche Patentschriften Nr. 859 470, i9 io6, 193 799; USA.-Patentschriften Nr. 2 517 410, 2 575 344; Französische Patentschrift Nr. 377 382; Archiv der Pharmazie, Bd. 268 [193o], S. 568 ff.PATENT CLAIM: Process for the production of nitric acid esters of oxyalkylxanthines, characterized in that one oxyalkylxanthines in the oxyalkyl radical Contain at least 2 carbon atoms, preferably at low temperatures treated with conventional nitrating agents and the resulting nitric acid esters precipitates and isolates due to water or aqueous liquids. Dressed Publications German Patent Nos. 859 470, 19 io6, 193 799; U.S. Patents No. 2,517,410, 2,575,344; French Patent No. 377,382; Pharmacy Archives, Vol. 268 [193o], p. 568 ff.
DES34639A 1953-08-01 1953-08-01 Process for the preparation of nitric acid esters of oxyalkylxanthines Expired DE924085C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DES34639A DE924085C (en) 1953-08-01 1953-08-01 Process for the preparation of nitric acid esters of oxyalkylxanthines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DES34639A DE924085C (en) 1953-08-01 1953-08-01 Process for the preparation of nitric acid esters of oxyalkylxanthines

Publications (1)

Publication Number Publication Date
DE924085C true DE924085C (en) 1955-02-24

Family

ID=7481594

Family Applications (1)

Application Number Title Priority Date Filing Date
DES34639A Expired DE924085C (en) 1953-08-01 1953-08-01 Process for the preparation of nitric acid esters of oxyalkylxanthines

Country Status (1)

Country Link
DE (1) DE924085C (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1090219B (en) * 1957-01-28 1960-10-06 Arzneimittelfabrik Krewel Leuf Process for the preparation of nitric acid esters of dimethylxanthine derivatives
DE1100028B (en) * 1956-03-28 1961-02-23 Arzneimittelfabrik Krewel Leuf Process for the preparation of nitric acid esters of dialkyl-xanthine-carboxylic acidoxyalkylamides
DE1118205B (en) * 1959-05-30 1961-11-30 Dresden Arzneimittel Process for the preparation of nitric acid esters of Oxyalkyltheophyllinen
DE1225649B (en) * 1961-10-05 1966-09-29 Robert Pfleger Chem Fab Dr Process for the preparation of salts of the nitric acid esters of 7-hydroxyalkylaminoalkyltheophyllines
EP1829523A1 (en) * 2006-03-01 2007-09-05 L'oreal Cosmetic use of an N-oxide derivative of theophylline

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19106C (en) * AD. LEXOW in Berlin S., Dresdenerstr. 43 Special machine for the mass production of the individual parts for piano mechanics
DE193799C (en) *
FR377382A (en) * 1906-08-08 1907-09-05 Societe Farbenfabriken Vorm. Friedr. Bayer & C° Process for the production of oxyalkylated derivatives of xanthine or its homologues
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof
US2575344A (en) * 1946-03-01 1951-11-20 State Of Iowa Dihydroxypropyl theophylline
DE859470C (en) * 1943-07-11 1952-12-15 Byk Gulden Lomberg Chem Fab Process for the production of therapeutically active substances from theophylline

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19106C (en) * AD. LEXOW in Berlin S., Dresdenerstr. 43 Special machine for the mass production of the individual parts for piano mechanics
DE193799C (en) *
FR377382A (en) * 1906-08-08 1907-09-05 Societe Farbenfabriken Vorm. Friedr. Bayer & C° Process for the production of oxyalkylated derivatives of xanthine or its homologues
DE859470C (en) * 1943-07-11 1952-12-15 Byk Gulden Lomberg Chem Fab Process for the production of therapeutically active substances from theophylline
US2575344A (en) * 1946-03-01 1951-11-20 State Of Iowa Dihydroxypropyl theophylline
US2517410A (en) * 1947-08-15 1950-08-01 Searle & Co Hydroxy alkyl xanthines and the production thereof

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1100028B (en) * 1956-03-28 1961-02-23 Arzneimittelfabrik Krewel Leuf Process for the preparation of nitric acid esters of dialkyl-xanthine-carboxylic acidoxyalkylamides
DE1090219B (en) * 1957-01-28 1960-10-06 Arzneimittelfabrik Krewel Leuf Process for the preparation of nitric acid esters of dimethylxanthine derivatives
DE1118205B (en) * 1959-05-30 1961-11-30 Dresden Arzneimittel Process for the preparation of nitric acid esters of Oxyalkyltheophyllinen
DE1225649B (en) * 1961-10-05 1966-09-29 Robert Pfleger Chem Fab Dr Process for the preparation of salts of the nitric acid esters of 7-hydroxyalkylaminoalkyltheophyllines
EP1829523A1 (en) * 2006-03-01 2007-09-05 L'oreal Cosmetic use of an N-oxide derivative of theophylline
FR2898048A1 (en) * 2006-03-01 2007-09-07 Oreal COSMETIC USE OF THEOPHYLLINE N-OXIDE DERIVATIVE

Similar Documents

Publication Publication Date Title
DE924085C (en) Process for the preparation of nitric acid esters of oxyalkylxanthines
DE617508C (en) Process for the production of pure lecithin
DE629662C (en) Process for the production of a concentrated, durable, aqueous theophylline solution
DE907293C (en) Process for the preparation of polysulfuric acid esters and salts thereof
DE876441C (en) Process for the production of a knitted body from hawthorn
US3071511A (en) Prednisolone-21-oenanthate octyldodecanol eye lotion
DE137207C (en)
DE706341C (en) Process for the production of water-swollen shrink capsules
AT69784B (en) Process for the preparation of acetone-soluble acidyl celluloses.
AT253677B (en) Process for the isolation of a centrally sedative isovaleric acid ester from non-aqueous valerian extracts
DE859470C (en) Process for the production of therapeutically active substances from theophylline
AT223326B (en) Process for the preparation of complex compounds of chloramphenicol
AT214328B (en) Process for retarding the rate of gelatinization in the manufacture of gelatinous or semi-gelatinous explosives
DE977653C (en) Process for the direct production of mixed nitric acid esters from polyalcohols
DE65110C (en) Process for the preparation of o-methoxy-ana-acetylamidoquinoline. (2
AT204706B (en) Process for obtaining reserpine-free deserpidine
DE508167C (en) Production of shelf-stable chlorinated lime
DE1568062C3 (en) Process for the preparation of 17alpha-acetoxy-Sbeta-hydroxy-o-chlorpregnan-4,6-dien-20-one. Eliminated from: 1241825
DE1058520B (en) Process for obtaining reserpine-free deserpidine
AT223330B (en) Process for the preparation of new morphine-bis-pyridinecarboxylic acid esters
DE653934C (en) Process for the preparation of carbonic acid esters of sex hormones
DE528268C (en) Process for the preparation of porphyrins
AT217159B (en) Process for the preparation of aqueous solutions of corticosteroids
DE957030C (en) Process for the preparation of the phenylpropionic acid esters of steroid hormones
DE1147222B (en) Process for the production of chemically pure dihydrostrophanthin